Improved virologic suppression with HIV subspecialty care in a large prison system using telemedicine: An observational study with historical controls

Clinical Infectious Diseases

Volumn 59, Issue 1, 2014, Pages 123-126

  Young, Jeremy D ^a   Patel, Mahesh ^a   Badowski, Melissa ^b   Mackesy Amiti, Mary Ellen ^a   Vaughn, Pyrai ^a   Shicker, Louis ^c   Puisis, Michael ^a   Ouellet, Lawrence J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Chicago College of Pharmacy   (United States)

^c Illinois Department of Corrections   (United States)

Author keywords

HIV; prisons; telehealth; telemedicine

Indexed keywords

CD4 ANTIGEN; ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PRISON; TELEMEDICINE; VIRUS LOAD; VIRUS TRANSMISSION; ADOLESCENT; COHORT ANALYSIS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; PROCEDURES; TREATMENT OUTCOME; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; HIV; HIV INFECTIONS; HUMANS; MIDDLE AGED; PRISONS; TELEMEDICINE; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 84904018589     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu222     Document Type: Article

References (29)

1. Campsmith ML, Rhodes P, Hall HI, Green T. HIV prevalence estimates-United States, 2006. JAMA 2009; 301:27-9.
2. Maruschak LM. HIV in prisons, 2006. Bureau of Justice Statistics, Department of Justice, 2006. Available at: www.ojp.usdoj.gov/bjs/pub/pdf/hivp06. pdf. Accessed 22 April 2013.
3. Spaulding AC, Seals RM, Page MJ, et al. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS One 2009; 4: e7558.
4. Rosen L, Manor O, Engelhard D, Zucker D. In defense of the randomized controlled trial for health promotion research. Am J Public Health 2006; 96:1181-6.
5. Nakashima A, Campsmith M, Wolfe M, et al. Late versus early testing of HIV, 16 sites, United States, 2000-2003. MMWR Morb Mortal Wkly Rep 2003; 52:581-6.
6. Keruly JC, Moore RD. Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006. Clin Infect Dis 2007; 45:1369-74.
7. Lemly DC, Shepherd BE, Hulgan T, et al. Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care. J Infect Dis 2009; 199:991-8.
8. Woldemichael G, Christiansen D, Thomas S, Benbow N. Demographic characteristics and survival with AIDS: health disparities in Chicago, 1993-2001. Am J Public Health 2009; 99:S118-23.
9. Gebo KA, Fleishman JA, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr 2005; 38:96-103.
10. Palacio H, Kahn JG, Richards TA, Morin SF. Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature. Public Health Rep 2002; 117:233-51; discussion 231-2.
11. Cohen MH, Cook JA, Grey D, et al. Medically eligible women who do not use HAART: the importance of abuse, drug use, and race. Am J Public Health 2004; 94:1147-51.
12. Li X, Margolick JB, Conover CS, et al. Interruption and discontinuation of highly active antiretroviral therapy in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 2005; 38:320-8.
13. Yuan Y, L'Italien G, Mukherjee J, Iloeje UH. Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort. HIV Med 2006; 7:156-62.
14. Pence BW, Ostermann J, Kumar V, Whetten K, Thielman N, Mugavero MJ. The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy. J Acquir Immune Defic Syndr 2008; 47:194-201.
15. Wakeman SE, Rich JD. HIV treatment in US prisons. HIV Ther 2010; 4: 505-10.
16. King RS, Mauer M, Huling T. Big prisons, small towns: prison economics in rural America. The Sentencing Project, 2003. Available at: www. sentencingproject.org. Accessed 24 April 2013.
17. Kitahata MM, Koepsell TD, Deyo RA, et al. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med 1996; 334:701-6.
18. Laine C, Markson LE, McKee LJ, et al. The relationship of clinic experience with advanced HIV and survival of women with AIDS. AIDS 1998; 12:417-24.
19. Delgado J, Heath KV, Yip B, et al. Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refill. Antivir Ther 2003; 8:471-8.
20. Landon BE, Wilson IB, McInnes K, et al. Physician specialization and the quality of care for human immunodeficiency virus infection. Arch Intern Med 2005; 165:1133-9.
21. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 342: 921-9.
22. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360: 1815-26.
23. Attia S, Egger M, Müller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009; 23:1431-3.
24. Sterne JA, May M, Costagiola D, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009; 373:1352-63.
25. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV infection with early antiretroviral therapy. New Engl J Med 2011; 365: 493-505.
26. Zaylor C, Nelson EL, Cook DJ. Clinical outcomes in a prison telepsychiatry clinic. J Telemed Telecare 2001; 7(suppl 1):47-9.
27. Lavrentyev V, Seay A, Rafiq A, Justis D, Merrell RC. A surgical telemedicine clinic in a correctional setting. Telemed J E Health 2008; 14:385-8.
28. Ellis DG, Mayrose J, Jehle DV, Moscati RM, Pierluisi GJ. A telemedicine model for emergency care in a short-term correctional facility. Telemed J E Health 2001; 7:87-92.
29. Das-Douglas M, Chu P, Santos G-M, et al. Decreases in community viral load are associated with a reduction in new HIV diagnoses in San Francisco, 2010. In: 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 2010.